Golden Gate Ventures MENA
Biosapien extends Pre-Series A round to $7 million
BioSapien, the pioneering biotech company behind MediChip, a revolutionary localized cancer treatment platform, has successfully extended its pre-Series A funding round to $7 million. This milestone i...